231 related articles for article (PubMed ID: 9328969)
1. Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency.
Wetzels JF; Reichert LJ
Kidney Int Suppl; 1997 Oct; 61():S63-6. PubMed ID: 9328969
[No Abstract] [Full Text] [Related]
2. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW; Branten AJ; Wetzels JF;
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
6. Alkylating agents in membranous nephropathy: efficacy proven beyond doubt.
Hofstra JM; Wetzels JF
Nephrol Dial Transplant; 2010 Jun; 25(6):1760-6. PubMed ID: 20133280
[No Abstract] [Full Text] [Related]
7. [Treatment of membranous nephropathy with chronic renal insufficiency].
Passerini P; Leoni A
G Ital Nefrol; 2008; 25 Suppl 44():76-82. PubMed ID: 19048590
[TBL] [Abstract][Full Text] [Related]
8. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
Ardiles LG; Mezzano SA
Clin Nephrol; 1996 Jun; 45(6):423. PubMed ID: 8793243
[No Abstract] [Full Text] [Related]
9. Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure.
Warwick GL; Geddes CG; Boulton-Jones JM
Q J Med; 1994 Apr; 87(4):223-9. PubMed ID: 8208913
[TBL] [Abstract][Full Text] [Related]
10. [Problems with immunosuppressive agents in nephropathies with chronic renal failure].
Savoldi S; Mesiano P; Rocchietti M
G Ital Nefrol; 2008; 25 Suppl 44():S38-S47. PubMed ID: 19048585
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
du Buf-Vereijken PW; Branten AJ; Wetzels JF
Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567
[TBL] [Abstract][Full Text] [Related]
12. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.
Hofstra JM; Wetzels JF
Nephrol Dial Transplant; 2008 Nov; 23(11):3534-8. PubMed ID: 18559961
[TBL] [Abstract][Full Text] [Related]
13. A difficult trade off for adults with membranous nephropathy.
BMJ; 2013 Jan; 346():f248. PubMed ID: 23325868
[No Abstract] [Full Text] [Related]
14. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
15. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
Naumovic R; Furuncic D; Jovanovic D; Stosovic M; Basta-Jovanovic G; Lezaic V
Biomed Pharmacother; 2010 Nov; 64(9):633-8. PubMed ID: 20888177
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
Hebert LA; Rovin BH; Agarwal AK; Spetie DN
Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
[No Abstract] [Full Text] [Related]
17. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
18. Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents.
Moroni G; Faricciotti A; Cappelletti M; Ponticelli C
Nephrol Dial Transplant; 1999 May; 14(5):1303-5. PubMed ID: 10344388
[No Abstract] [Full Text] [Related]
19. Retreatment of membranous nephropathy with steroids and chlorambucil after initial unresponsiveness to alternate-day prednisone.
Tietjen DP
Clin Nephrol; 1990 Mar; 33(3):152. PubMed ID: 2323113
[No Abstract] [Full Text] [Related]
20. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
Boumpas DT; Tassiulas IO; Fleisher TA; Vaughan E; Piscitelli S; Kim Y; Pucino F; Balow JE; Austin HA
Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
